Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

Disponibil de la:

Hospira Australia Pty Ltd

INN (nume internaţional):

irinotecan hydrochloride trihydrate

Forma farmaceutică:

Injection, intravenous infusion

Compoziție:

Excipient Ingredients: lactic acid; sorbitol; water for injections

Calea de administrare:

Intravenous Infusion

Unități în pachet:

1 x 5 mL vial

Clasă:

Medicine Listed (Export Only)

Tip de prescriptie medicala:

(S1) This Schedule is intentionally blank

Indicații terapeutice:

Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).

Rezumat produs:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2013-01-31